Understanding cytokine and growth factor receptor activation mechanisms
暂无分享,去创建一个
[1] D. Haylock,et al. Principal signalling complexes in haematopoiesis: structural aspects and mimetic discovery. , 2011, Cytokine & growth factor reviews.
[2] Michael L Doyle,et al. Selective Binding and Oligomerization of the Murine Granulocyte Colony-stimulating Factor Receptor by a Low Molecular Weight, Nonpeptidyl Ligand* , 2003, The Journal of Biological Chemistry.
[3] S. Bass,et al. Zinc mediation of the binding of human growth hormone to the human prolactin receptor. , 1990, Science.
[4] Quincy Teng,et al. Structural Biology , 2013, Springer US.
[5] S. Constantinescu,et al. Structural Requirements of the Extracellular to Transmembrane Domain Junction for Erythropoietin Receptor Function* , 2005, Journal of Biological Chemistry.
[6] P. Heinrich,et al. The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL‐6 and the IL‐6 receptor , 1995, FEBS letters.
[7] D. Harrison,et al. The JAK/STAT signaling pathway , 2004, Journal of Cell Science.
[8] B. Posner,et al. Cellular signalling: Peptide hormones and growth factors. , 2010, Progress in brain research.
[9] D. Lauffenburger,et al. Interleukin 2 (IL-2) variants engineered for increased IL-2 receptor alpha-subunit affinity exhibit increased potency arising from a cell surface ligand reservoir effect. , 2004, Molecular pharmacology.
[10] M. Emgenbroich,et al. Erythropoietin mimetic compound AGEM400(HES) binds to the same receptor as erythropoietin but displays a different spectrum of activities. , 2012, Cytokine.
[11] J G Gleason,et al. A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns]. , 1998, Science.
[12] Robert M Stroud,et al. Mechanistic Diversity of Cytokine Receptor Signaling Across Cell Membranes , 2004, Science's STKE.
[13] Hisashi Q. Higuchi. On the nature of , 1999 .
[14] Huawei Qiu,et al. Homodimerization Restores Biological Activity to an Inactive Erythropoietin Mutant* , 1998, The Journal of Biological Chemistry.
[15] C. Heldin,et al. Dimerization of cell surface receptors in signal transduction , 1995, Cell.
[16] A. Wilks,et al. Identification of JAK protein tyrosine kinases as signaling molecules for prolactin. Functional analysis of prolactin receptor and prolactin‐erythropoietin receptor chimera expressed in lymphoid cells. , 1994, The EMBO journal.
[17] A. Whitty,et al. Quantitative analysis of the activation mechanism of the multicomponent growth-factor receptor Ret , 2006, Nature chemical biology.
[18] J. Louis,et al. GDNF–Induced Activation of the Ret Protein Tyrosine Kinase Is Mediated by GDNFR-α, a Novel Receptor for GDNF , 1996, Cell.
[19] D. Chang,et al. Activation of the Erythropoietin (EPO) Receptor by Bivalent Anti-EPO Receptor Antibodies* , 1996, The Journal of Biological Chemistry.
[20] K. Rose,et al. Characterization of new multimeric erythropoietin receptor agonists , 2008, Biopolymers.
[21] L. D. Ward,et al. High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. , 1994, The Journal of biological chemistry.
[22] S. Skaper. Peptide mimetics of neurotrophins and their receptors. , 2011, Current pharmaceutical design.
[23] Yu-Chin Li,et al. Bivalent peptidomimetic ligands of TrkC are biased agonists and selectively induce neuritogenesis or potentiate neurotrophin-3 trophic signals. , 2009, ACS chemical biology.
[24] P. Gregersen,et al. Structural biology of shared cytokine receptors. , 2009, Annual review of immunology.
[25] Wen He,et al. An antagonist peptide–EPO receptor complex suggests that receptor dimerization is not sufficient for activation , 1998, Nature Structural Biology.
[26] I. Maruyama,et al. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells , 2008, Journal of Cell Science.
[27] H. Holtmann,et al. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. , 1990, The Journal of biological chemistry.
[28] P. Hass,et al. An agonist murine monoclonal antibody to the human c-Mpl receptor stimulates megakaryocytopoiesis. , 1998, Blood.
[29] J. Schlessinger. Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.
[30] D. Lauffenburger,et al. Affinity regulates spatial range of EGF receptor autocrine ligand binding. , 2002, Developmental biology.
[31] D. Boger,et al. Erythropoietin mimetics derived from solution phase combinatorial libraries. , 2002, Journal of the American Chemical Society.
[32] A. Walker,et al. Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists. , 2006, Molecular endocrinology.
[33] K Imada,et al. The Jak-STAT pathway. , 2000, Molecular immunology.
[34] N. Asai,et al. Calcium-dependent Ret activation by GDNF and neurturin , 1998, Oncogene.
[35] A. Citri,et al. Epigen, the Last Ligand of ErbB Receptors, Reveals Intricate Relationships between Affinity and Mitogenicity* , 2005, Journal of Biological Chemistry.
[36] D. Stein,et al. Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death , 2007, Proceedings of the National Academy of Sciences.
[37] Joseph Schlessinger,et al. Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.
[38] T. Pawson,et al. Assembly of Cell Regulatory Systems Through Protein Interaction Domains , 2003, Science.
[39] Linda J Pike,et al. Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system , 2008, Proceedings of the National Academy of Sciences.
[40] D. Goeddel,et al. Rational design of potent antagonists to the human growth hormone receptor. , 1992, Science.
[41] J. Tschopp,et al. The molecular architecture of the TNF superfamily. , 2002, Trends in biochemical sciences.
[42] A. Hinck,et al. Ternary Complex of Transforming Growth Factor-β1 Reveals Isoform-specific Ligand Recognition and Receptor Recruitment in the Superfamily* , 2010, The Journal of Biological Chemistry.
[43] S. Skaper. The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors. , 2008, CNS & neurological disorders drug targets.
[44] T. Waldmann,et al. Cooperative interactions between the interleukin 2 receptor alpha and beta chains alter the interleukin 2-binding affinity of the receptor subunits. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[45] D. Harrison,et al. The Jak/STAT pathway. , 2012, Cold Spring Harbor perspectives in biology.
[46] J. Schlessinger,et al. Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. , 1988, The Journal of biological chemistry.
[47] M. Bednarek,et al. Mimicry of erythropoietin by a nonpeptide molecule. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[48] Hong-Jian Zhu,et al. A Pivotal Role for the Transmembrane Domain in Transforming Growth Factor-β Receptor Activation* , 1999, The Journal of Biological Chemistry.
[49] B. Ursø,et al. The insulin-like growth factor-I receptor. Structure, ligand-binding mechanism and signal transduction. , 1994, Hormone research.
[50] T. Waldmann,et al. Nanometer-scale organization of the alpha subunits of the receptors for IL2 and IL15 in human T lymphoma cells , 2008, Journal of Cell Science.
[51] H. Rui,et al. JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. , 1994, Endocrinology.
[52] David F. Burke,et al. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin , 2000, Nature.
[53] A. Ullrich,et al. Growth factor signaling by receptor tyrosine kinases , 1992, Neuron.
[54] J. Darnell,et al. The JAK-STAT pathway at twenty. , 2012, Immunity.
[55] H. Lodish,et al. The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif. , 2001, Molecular cell.
[56] Kai Simons,et al. Membrane organization and lipid rafts. , 2011, Cold Spring Harbor perspectives in biology.
[57] Yoshua Bengio,et al. Selective small molecule peptidomimetic ligands of TrkC and TrkA receptors afford discrete or complete neurotrophic activities. , 2005, Chemistry & biology.
[58] Ronald W. Barrett,et al. Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin , 1996, Science.
[59] Edouard C. Nice,et al. Ligand-induced Dimer-Tetramer Transition during the Activation of the Cell Surface Epidermal Growth Factor Receptor-A Multidimensional Microscopy Analysis* , 2005, Journal of Biological Chemistry.
[60] Derek Toomre,et al. Spatial control of EGF receptor activation by reversible dimerization on living cells , 2010, Nature.
[61] A. Hinck,et al. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent. , 2005, Journal of molecular biology.
[62] J. Massagué. TGF‐β signaling in development and disease , 2012, FEBS letters.
[63] A. D’Andrea,et al. A constitutively activated chimeric cytokine receptor confers factor-independent growth in hematopoietic cell lines. , 1996, Blood.
[64] D. Lauffenburger,et al. Ligand/Receptor Signaling Threshold (LIST) Model Accounts for gp130‐Mediated Embryonic Stem Cell Self‐Renewal Responses to LIF and HIL‐6 , 2002, Stem cells.
[65] M. Kawahara,et al. Selection of highly productive mammalian cells based on an inducible growth advantage using an antibody/receptor chimera. , 2002, Journal of bioscience and bioengineering.
[66] K. Fleming,et al. Dimerization of the erythropoietin receptor transmembrane domain in micelles. , 2007, Journal of molecular biology.
[67] H. Lodish,et al. Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[68] J. Tavernier,et al. Functional analysis of leptin receptor activation using a Janus kinase/signal transducer and activator of transcription complementation assay. , 2004, Molecular Endocrinology.
[69] B. Goldstein,et al. Solution Assembly of a Soluble, Heteromeric, High Affinity Interleukin-2 Receptor Complex (*) , 1995, The Journal of Biological Chemistry.
[70] K. Garcia,et al. Shared cytokine signaling receptors: structural insights from the gp130 system. , 2004, Advances in protein chemistry.
[71] S. Masuda,et al. An extra high dose of erythropoietin fails to support the proliferation of erythropoietin dependent cell lines , 2011, Cytotechnology (Dordrecht).
[72] K. Ferguson,et al. Structure-based view of epidermal growth factor receptor regulation. , 2008, Annual review of biophysics.
[73] Mart Saarma,et al. The GDNF family: Signalling, biological functions and therapeutic value , 2002, Nature Reviews Neuroscience.
[74] W. Vainchenker,et al. An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor. , 2006, Blood.
[75] M. Auer,et al. Beyond dimerization: a membrane-dependent activation model for interleukin-4 receptor-mediated signalling. , 2007, Journal of molecular biology.
[76] P. Sathyanarayana,et al. CNTO 530 functions as a potent EPO mimetic via unique sustained effects on bone marrow proerythroblast pools. , 2009, Blood.
[77] J. O’Shea,et al. Janus kinases in immune cell signaling , 2009, Immunological reviews.
[78] P. De Meyts,et al. Receptor dimerization determines the effects of growth hormone in primary rat adipocytes and cultured human IM-9 lymphocytes. , 1994, Endocrinology.
[79] R. Daly,et al. Docking proteins , 2010, The FEBS journal.
[80] Y. Yarden,et al. The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[81] John Kuriyan,et al. An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor , 2006, Cell.
[82] Masashi Suzuki,et al. Sulfated Glycosaminoglycans Are Required for Specific and Sensitive Fibroblast Growth Factor (FGF) 19 Signaling via FGF Receptor 4 and betaKlotho* , 2011, The Journal of Biological Chemistry.
[83] S. Sprang,et al. Seeing double: Crystal structures of the type I TNF receptor , 1996, Journal of molecular recognition : JMR.
[84] M. Wada,et al. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the effect on the human prolactin receptor. , 1999, Endocrinology.
[85] Hitoshi Sakuraba,et al. ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth , 2004, Journal of Cell Science.
[86] M. Kawahara,et al. T cell growth control using hapten-specific antibody/interleukin-2 receptor chimera. , 2009, Cytokine.
[87] Huan-Xiang Zhou,et al. A Common Model for Cytokine Receptor Activation: Combined Scissor-Like Rotation and Self-Rotation of Receptor Dimer Induced by Class I Cytokine , 2012, PLoS Comput. Biol..
[88] R. Zivin,et al. Amino-terminal dimerization of an erythropoietin mimetic peptide results in increased erythropoietic activity. , 1997, Chemistry & biology.
[89] Peter Klein,et al. A structure-based model for ligand binding and dimerization of EGF receptors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[90] M. Bilgen,et al. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. , 2010, The Journal of clinical investigation.
[91] Yen-Ming Hsu,et al. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. , 2005, Biochemistry.
[92] A. Hinck,et al. Assembly of TβRI: TβRII:TGFβ ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent , 2005 .
[93] Diego Jaitin,et al. Inquiring into the Differential Action of Interferons (IFNs): an IFN-α2 Mutant with Enhanced Affinity to IFNAR1 Is Functionally Similar to IFN-β , 2006, Molecular and Cellular Biology.
[94] R. Germain,et al. T-cell signaling: The importance of receptor clustering , 1997, Current Biology.
[95] N. Udagawa,et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[96] Michael Loran Dustin,et al. Analysis of two-dimensional dissociation constant of laterally mobile cell adhesion molecules. , 2007, Biophysical journal.
[97] K. Ballmer-Hofer,et al. Transmembrane domain‐mediated orientation of receptor monomers in active VEGFR‐2 dimers , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[98] M. Ballmaier,et al. Grafting of thrombopoietin‐mimetic peptides into cystine knot miniproteins yields high‐affinity thrombopoietin antagonists and agonists , 2006, The FEBS journal.
[99] L. Pike,et al. The Intracellular Juxtamembrane Domain of the Epidermal Growth Factor (EGF) Receptor Is Responsible for the Allosteric Regulation of EGF Binding*♦ , 2009, Journal of Biological Chemistry.
[100] J. Scheller,et al. gp130 dimerization in the absence of ligand: preformed cytokine receptor complexes. , 2006, Biochemical and biophysical research communications.
[101] T. Malek,et al. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. , 2010, Immunity.
[102] H. Lodish,et al. Homodimerization and constitutive activation of the erythropoietin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[103] J. Beechem,et al. Preparation and characterization of Alexa Fluor 594-labeled epidermal growth factor for fluorescence resonance energy transfer studies: application to the epidermal growth factor receptor. , 2004, Analytical biochemistry.
[104] L. Barbeito,et al. Modulation of p75NTR‐dependent motor neuron death by a small non‐peptidyl mimetic of the neurotrophin loop 1 domain , 2006, The European journal of neuroscience.
[105] M. Kawahara,et al. Growth control of genetically modified cells using an antibody/c-Kit chimera. , 2012, Journal of bioscience and bioengineering.
[106] Junxia Xie,et al. PREASSEMBLY AND LIGAND-INDUCED CHANGES OF THE INTERFERON RECEPTOR COMPLEX IN CELLS* , 2002 .
[107] E. Wolf,et al. The epidermal growth factor receptor ligands at a glance , 2009, Journal of cellular physiology.
[108] Wei Cheng,et al. Characterization of a soluble ternary complex formed between human interferon‐β‐1a and its receptor chains , 1999, Protein science : a publication of the Protein Society.
[109] K. Christopher Garcia,et al. Molecular and Structural Basis of Cytokine Receptor Pleiotropy in the Interleukin-4/13 System , 2008, Cell.
[110] K. Garcia,et al. Hexameric Structure and Assembly of the Interleukin-6/IL-6 α-Receptor/gp130 Complex , 2003, Science.
[111] J K Frederiksen,et al. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. , 2000, Science.
[112] A Whitty,et al. Small molecule cytokine mimetics. , 1999, Chemistry & biology.
[113] K. Norga,et al. Receptors that induce erythroid differentiation of Ba/F3 cells: structural requirements and effect on STAT5 binding. , 1997, Blood.
[114] T. Walz,et al. Ligand binding induces a conformational change in ifnar1 that is propagated to its membrane-proximal domain. , 2008, Journal of molecular biology.
[115] M. Kawahara,et al. Growth promotion of genetically modified hematopoietic progenitors using an antibody/c-Mpl chimera. , 2011, Cytokine.
[116] M. Gavutis,et al. Differential receptor subunit affinities of type I interferons govern differential signal activation. , 2007, Journal of molecular biology.
[117] S. Sharpe,et al. Interaction between ErbB‐1 and ErbB‐2 transmembrane domains in bilayer membranes , 2002, FEBS letters.
[118] G. Blumenschein. Insulin-like growth factor receptor. , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[119] Michael W Parker,et al. Model for growth hormone receptor activation based on subunit rotation within a receptor dimer , 2005, Nature Structural &Molecular Biology.
[120] Diego Jaitin,et al. The Stability of the Ternary Interferon-Receptor Complex Rather than the Affinity to the Individual Subunits Dictates Differential Biological Activities* , 2008, Journal of Biological Chemistry.
[121] L. Alberghina,et al. A New Nerve Growth Factor-Mimetic Peptide Active on Neuropathic Pain in Rats , 2008, The Journal of Neuroscience.
[122] Robert M. Stroud,et al. Efficiency of signalling through cytokine receptors depends critically on receptor orientation , 1998, Nature.
[123] D. Nikolov,et al. Cell-cell signaling via Eph receptors and ephrins. , 2007, Current opinion in cell biology.
[124] J. Baselga,et al. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 , 2009, Nature Reviews Cancer.
[125] Adrian Whitty,et al. Cooperativity and biological complexity. , 2008, Nature chemical biology.
[126] M. Boyle,et al. Homodimerization of erythropoietin receptor by a bivalent monoclonal antibody triggers cell proliferation and differentiation of erythroid precursors. , 1997, Blood.
[127] Xiangling Xiong,et al. Nanoparticle-mediated IgE-receptor aggregation and signaling in RBL mast cells. , 2009, Journal of the American Chemical Society.
[128] Y Ikeda,et al. A non‐peptide compound which can mimic the effect of thrombopoietin via c‐Mpl , 1998, FEBS letters.
[129] O. Bocharova,et al. Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases. , 2010, Journal of molecular biology.
[130] D. Aunis,et al. Transmembrane peptides as inhibitors of ErbB receptor signaling. , 2004, Molecular biology of the cell.
[131] D. Baccanari,et al. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. , 1997, Science.
[132] C. D. Krause,et al. Interferons, interferon‐like cytokines, and their receptors , 2004, Immunological reviews.
[133] A. Arseniev,et al. Transmembrane domain of EphA1 receptor forms dimers in membrane-like environment. , 2008, Biochimica et biophysica acta.
[134] H. Miyazaki,et al. Switching constant domains enhances agonist activities of antibodies to a thrombopoietin receptor , 2008, Nature Biotechnology.
[135] J. Bussel,et al. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study , 2011, The Lancet.
[136] T M Jovin,et al. Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation , 1995, The Journal of cell biology.
[137] D A Lauffenburger,et al. Analysis of Mammalian Cell Growth Factor Receptor Dynamics a , 1987, Annals of the New York Academy of Sciences.
[138] M. Saarma,et al. GDNF Family Neurotrophic Factor Signaling: Four Masters, One Servant? , 1999, Molecular and Cellular Neuroscience.
[139] D. Banner,et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation , 1993, Cell.
[140] Joanne Oates,et al. Strong oligomerization behavior of PDGFbeta receptor transmembrane domain and its regulation by the juxtamembrane regions. , 2010, Biochimica et biophysica acta.
[141] S. Constantinescu,et al. Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer. , 2003, Molecular cell.
[142] T. Jovin,et al. Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis , 2010, Proceedings of the National Academy of Sciences.
[143] Ursula Klingmüller,et al. Self assembly of the transmembrane domain promotes signal transduction through the erythropoietin receptor , 2001, Current Biology.
[144] I. Chaiken,et al. Interleukin-5 Receptor Subunit Oligomerization and Rearrangement Revealed by Fluorescence Resonance Energy Transfer Imaging* , 2008, Journal of Biological Chemistry.
[145] Angel F. Lopez,et al. Molecular assembly of the ternary granulocyte-macrophage colony-stimulating factor receptor complex. , 2003, Blood.
[146] M. Ballinger,et al. Will any dimer do? , 1998, Nature Structural Biology.
[147] Alan E Mark,et al. Turning the growth hormone receptor on: Evidence that hormone binding induces subunit rotation , 2010, Proteins.
[148] G. Yancopoulos,et al. The alphas, betas, and kinases of cytokine receptor complexes , 1993, Cell.
[149] C. Heldin,et al. Specificity, diversity, and regulation in TGF‐β superfamily signaling , 1999 .
[150] A. Buj-Bello,et al. Characterization of a multicomponent receptor for GDNF , 1996, Nature.
[151] Mark A. Hall,et al. Interleukin-11 Signals through the Formation of a Hexameric Receptor Complex* , 2000, The Journal of Biological Chemistry.
[152] A. Bader,et al. Ligand-induced EGF Receptor Oligomerization Is Kinase-dependent and Enhances Internalization* , 2010, The Journal of Biological Chemistry.
[153] P. W. Janes,et al. Architecture of Eph receptor clusters , 2010, Proceedings of the National Academy of Sciences.
[154] I. Jang,et al. Grb2, a simple adapter with complex roles in lymphocyte development, function, and signaling , 2009, Immunological reviews.
[155] Wei Liu,et al. Functional impact of manipulation on the relative orientation of human prolactin receptor domains. , 2011, Biochemistry.
[156] T. Arakawa,et al. Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction. , 1996, Biochemistry.
[157] K. Clauser,et al. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. , 1991, Science.
[158] P. Pilch,et al. Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[159] I. Ishida,et al. Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2 , 2004, Cell Death and Differentiation.
[160] M. Waters,et al. Activation of Chimeric and Full-length Growth Hormone Receptors by Growth Hormone Receptor Monoclonal Antibodies , 1998, The Journal of Biological Chemistry.
[161] H. Loetscher,et al. Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors , 1990, The Journal of experimental medicine.
[162] Michael Loran Dustin,et al. Low Affinity Interaction of Human or Rat T Cell Adhesion Molecule CD2 with Its Ligand Aligns Adhering Membranes to Achieve High Physiological Affinity* , 1997, The Journal of Biological Chemistry.
[163] Peter Klein,et al. On the nature of low- and high-affinity EGF receptors on living cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[164] R. Adar,et al. Differential Activation of Cysteine‐Substitution Mutants of Fibroblast Growth Factor Receptor 3 Is Determined by Cysteine Localization , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[165] L. Willen,et al. Molecular and Therapeutic Characterization of Anti-ectodysplasin A Receptor (EDAR) Agonist Monoclonal Antibodies* , 2011, The Journal of Biological Chemistry.
[166] L S Mulcahy,et al. Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1. , 1998, Biochemistry.
[167] Patrick England,et al. Structural characterization of the stem-stem dimerization interface between prolactin receptor chains complexed with the natural hormone. , 2010, Journal of molecular biology.
[168] Jae-Hoon Kim,et al. Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains , 2002, Cell.
[169] K. Burgess,et al. Long-Lasting Rescue of Age-Associated Deficits in Cognition and the CNS Cholinergic Phenotype by a Partial Agonist Peptidomimetic Ligand of TrkA , 2004, The Journal of Neuroscience.
[170] I. Wilson,et al. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. , 1999, Science.
[171] H. Lodish,et al. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization , 1994, Molecular and cellular biology.
[172] M. Lemmon,et al. The Single Transmembrane Domains of ErbB Receptors Self-associate in Cell Membranes* , 2002, The Journal of Biological Chemistry.
[173] I. Wilson,et al. The structure, organization, activation and plasticity of the erythropoietin receptor. , 1999, Current opinion in structural biology.
[174] Pascal Schneider,et al. Two Adjacent Trimeric Fas Ligands Are Required for Fas Signaling and Formation of a Death-Inducing Signaling Complex , 2003, Molecular and Cellular Biology.
[175] R. Harris,et al. Autocrine, paracrine and juxtacrine signaling by EGFR ligands. , 2005, Cellular signalling.
[176] E. Elson,et al. Oligomerization of the EGF receptor investigated by live cell fluorescence intensity distribution analysis. , 2007, Biophysical journal.
[177] S R Sprang,et al. Structures of the extracellular domain of the type I tumor necrosis factor receptor. , 1996, Structure.
[178] Y. Yarden,et al. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. , 1987, Biochemistry.
[179] A. Whitty,et al. Interaction affinity between cytokine receptor components on the cell surface. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[180] Y. Maeda,et al. Structural remodeling, trafficking and functions of glycosylphosphatidylinositol-anchored proteins. , 2011, Progress in lipid research.
[181] R. Lier,et al. Common γ chain cytokines: Dissidence in the details , 2007 .
[182] H. Lodish,et al. Active Conformation of the Erythropoietin Receptor , 2006, Journal of Biological Chemistry.
[183] A. Yoshimura,et al. Ligand-induced activation of chimeric receptors between the erythropoietin receptor and receptor tyrosine kinases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[184] I. Wilson,et al. Erythropoietin receptor activation by a ligand-induced conformation change. , 1999, Science.
[185] Jacob Piehler,et al. Determination of the two-dimensional interaction rate constants of a cytokine receptor complex. , 2006, Biophysical journal.
[186] Enrico A. Stura,et al. Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å , 1996, Science.
[187] E. Whitehorn,et al. A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chains. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[188] Peter O. Krutzik,et al. Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons , 2011, Cell.
[189] C. Peng,et al. Activin receptor-like kinases: structure, function and clinical implications. , 2006, Endocrine, metabolic & immune disorders drug targets.
[190] A. C. Rigby,et al. Oligomerization of the EGF receptor transmembrane domain: a 2H NMR study in lipid bilayers. , 1997, Biochemistry.
[191] D. Blumenthal,et al. PDGF‐induced proliferation in human arterial and venous smooth muscle cells: Molecular basis for differential effects of PDGF isoforms , 2011, Journal of cellular biochemistry.
[192] A. Whitty,et al. New ways to target old receptors. , 2008, Current opinion in chemical biology.
[193] J. Torres,et al. The strong dimerization of the transmembrane domain of the fibroblast growth factor receptor (FGFR) is modulated by C‐terminal juxtamembrane residues , 2009, Protein science : a publication of the Protein Society.
[194] M. Brizzi,et al. Prolactin increases the susceptibility of primary leukemia cells to NK and LAK effectors. , 1996, Advances in neuroimmunology.
[195] C. Heldin,et al. Ligand-induced dimerization of growth factor receptors: variations on the theme. , 1996, Cytokine & growth factor reviews.
[196] Holger Conzelmann,et al. Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding. , 2011, Molecular cell.
[197] Gideon Schreiber,et al. Stochastic Receptor Expression Determines Cell Fate upon Interferon Treatment , 2011, Molecular and Cellular Biology.
[198] M. Lemmon,et al. Structural Basis for Negative Cooperativity in Growth Factor Binding to an EGF Receptor , 2010, Cell.
[199] P. Comoglio,et al. Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF. , 1998, Journal of cell science.
[200] S. Harper,et al. Trk Neurotrophin Receptor Activators. , 2002, Drug news & perspectives.
[201] Yang Liu,et al. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone , 2010, Proceedings of the National Academy of Sciences.
[202] S. Lata,et al. Lateral ligand-receptor interactions on membranes probed by simultaneous fluorescence-interference detection. , 2005, Biophysical journal.
[203] B. Klein,et al. An agonist anti-human CD40 monoclonal antibody that induces dendritic cell formation and maturation and inhibits proliferation of a myeloma cell line. , 1999, Hybridoma.
[204] S. Lata,et al. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers. , 2004, Journal of molecular biology.
[205] D. Boger,et al. Cytokine receptor dimerization and activation: prospects for small molecule agonists. , 2001, Bioorganic & medicinal chemistry.
[206] M. Kawahara,et al. Mimicry of erythropoietin and interleukin-6 signalling by an antibody/cytokine receptor chimera in murine myeloid 32D cells. , 2007, Journal of biochemistry.
[207] R M Siegel,et al. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. , 2000, Science.
[208] P. Knaus,et al. Recent advances in BMP receptor signaling. , 2009, Cytokine & growth factor reviews.
[209] Roman G. Efremov,et al. Spatial Structure of the Dimeric Transmembrane Domain of the Growth Factor Receptor ErbB2 Presumably Corresponding to the Receptor Active State* , 2008, Journal of Biological Chemistry.
[210] R. Quirion,et al. Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[211] W. Sebald,et al. Conversion of human interleukin‐4 into a high affinity antagonist by a single amino acid replacement. , 1992, The EMBO journal.
[212] S. Watowich. Activation of erythropoietin signaling by receptor dimerization. , 1999, The international journal of biochemistry & cell biology.
[213] D. Lauffenburger,et al. Interleukin 2 (IL-2) variants engineered for increased IL-2 receptor α-subunit affinity exhibit increased potency arising from a cell surface ligand reservoir effect , 2004 .
[214] Ian A Wilson,et al. Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[215] L. Cantley,et al. Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[216] R. D'Andrea,et al. Molecular basis of cytokine receptor activation , 2010, IUBMB life.
[217] L. Mátyus,et al. Non-random distribution of interleukin receptors on the cell surface. , 2009, Chemphyschem : a European journal of chemical physics and physical chemistry.
[218] Miho Suzuki,et al. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. , 2012, Clinical science.
[219] D. Christiansen,et al. Inducible Dimerization of RET Reveals a Specific AKT Deregulation in Oncogenic Signaling* , 2005, Journal of Biological Chemistry.
[220] G. Forte,et al. Agonist monoclonal antibodies against HGF receptor protect cardiac muscle cells from apoptosis. , 2010, American journal of physiology. Heart and circulatory physiology.
[221] T. Honjo,et al. Why are multiple chains required for the interleukin 2 receptor? , 1990, Progress in growth factor research.